These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31396736)

  • 1. Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study.
    Oue T; Fukumoto K; Souzaki R; Takimoto T; Koshinaga T;
    Pediatr Surg Int; 2019 Oct; 35(10):1095-1099. PubMed ID: 31396736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
    Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.
    Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y;
    Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3.
    Ritchey ML; Pringle KC; Breslow NE; Takashima J; Moksness J; Zuppan CW; Beckwith JB; Thomas PR; Kelalis PP
    Ann Surg; 1994 Nov; 220(5):683-90. PubMed ID: 7979618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
    Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
    Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4.
    Shamberger RC; Guthrie KA; Ritchey ML; Haase GM; Takashima J; Beckwith JB; D'Angio GJ; Green DM; Breslow NE
    Ann Surg; 1999 Feb; 229(2):292-7. PubMed ID: 10024113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.
    Spreafico F; Biasoni D; Lo Vullo S; Gandola L; D'Angelo P; Terenziani M; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Morosi C; Perotti D; Catania S; Bellani FF; Collini P;
    J Urol; 2017 Nov; 198(5):1138-1145. PubMed ID: 28655531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
    Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
    Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Wilms tumors treated according to the Japan Wilms Tumor Study Group protocol.
    Oue T; Koshinaga T; Okita H; Kaneko Y; Hinotsu S; Fukuzawa M
    Pediatr Blood Cancer; 2014 Jul; 61(7):1184-9. PubMed ID: 24623612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
    Hamilton TE; Ritchey ML; Haase GM; Argani P; Peterson SM; Anderson JR; Green DM; Shamberger RC
    Ann Surg; 2011 May; 253(5):1004-10. PubMed ID: 21394016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment strategy for children with Wilms tumor].
    Fukuzawa M
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group.
    Oue T; Fukuzawa M; Koshinaga T; Okita H; Nozaki M; Chin M; Kaneko Y; Tanaka Y; Haruta M; Tsuchiya K; Kuwajima S; Takimoto T
    Pediatr Int; 2015 Oct; 57(5):828-31. PubMed ID: 26267611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.